These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9972142)

  • 21. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
    Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ
    Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature.
    Dodd BR; Spence RA
    Curr Vasc Pharmacol; 2011 Jul; 9(4):471-8. PubMed ID: 21595625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice.
    Prall AK; Longo GM; Mayhan WG; Waltke EA; Fleckten B; Thompson RW; Baxter BT
    J Vasc Surg; 2002 May; 35(5):923-9. PubMed ID: 12021708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin suppresses experimental aortic aneurysm growth.
    Lawrence DM; Singh RS; Franklin DP; Carey DJ; Elmore JR
    J Vasc Surg; 2004 Aug; 40(2):334-8. PubMed ID: 15297830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filling of the aneurysmal sac with DEAC-glucosamine in an animal model of abdominal aortic aneurysm following stent-graft repair.
    Uflacker R; Brothers T
    J Cardiovasc Surg (Torino); 2006 Aug; 47(4):425-36. PubMed ID: 16953162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.
    Ogata T; Shibamura H; Tromp G; Sinha M; Goddard KA; Sakalihasan N; Limet R; MacKean GL; Arthur C; Sueda T; Land S; Kuivaniemi H
    J Vasc Surg; 2005 Jun; 41(6):1036-42. PubMed ID: 15944607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases and their inhibition in periodontal treatment.
    Ryan ME; Ramamurthy S; Golub LM
    Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
    Sinha S; Frishman WH
    J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice.
    Yoshimura K; Aoki H; Ikeda Y; Furutani A; Hamano K; Matsuzaki M
    Ann N Y Acad Sci; 2006 Nov; 1085():74-81. PubMed ID: 17182924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms.
    Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG
    Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
    Vinh A; Gaspari TA; Liu HB; Dousha LF; Widdop RE; Dear AE
    J Vasc Res; 2008; 45(2):143-52. PubMed ID: 17957103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.
    Aziz F; Kuivaniemi H
    Ann Vasc Surg; 2007 May; 21(3):392-401. PubMed ID: 17484978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel pharmacological approaches in abdominal aortic aneurysm.
    Puertas-Umbert L; Almendra-Pegueros R; Jiménez-Altayó F; Sirvent M; Galán M; Martínez-González J; Rodríguez C
    Clin Sci (Lond); 2023 Aug; 137(15):1167-1194. PubMed ID: 37559446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of matrix metalloproteinases in abdominal aortic aneurysms.
    Thompson RW; Parks WC
    Ann N Y Acad Sci; 1996 Nov; 800():157-74. PubMed ID: 8958991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development.
    Palmieri D; Pane B; Barisione C; Spinella G; Garibaldi S; Ghigliotti G; Brunelli C; Fulcheri E; Palombo D
    J Surg Res; 2011 Dec; 171(2):e237-46. PubMed ID: 21962734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of experimental abdominal aortic aneurysms in the mice by treatment with Ginkgo biloba extract (EGb 761).
    Wang L; Bai Y; Wang B; Cui H; Wu H; Lv JR; Mei Y; Zhang JS; Liu S; Qi LW; Chen Y
    J Ethnopharmacol; 2013 Oct; 150(1):308-15. PubMed ID: 24012526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture.
    Rentschler M; Baxter BT
    Ann N Y Acad Sci; 2006 Nov; 1085():39-46. PubMed ID: 17182921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
    Xiong W; Knispel R; Mactaggart J; Baxter BT
    J Vasc Surg; 2006 Nov; 44(5):1061-6. PubMed ID: 17098543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
    Evans J; Powell JT; Schwalbe E; Loftus IM; Thompson MM
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):302-3. PubMed ID: 17574455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model.
    Miwa K; Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2005 Jul; 12(14):1109-18. PubMed ID: 15800662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.